Lucideon White Paper Discusses Advances Being Made in Controlled Release Fertiliser Technology

Lucideon, the international materials technology company, has published a new white paper, ‘The Role of Controlled Release Fertilisers in Sustainable Crop Growth’.

The white paper discusses the advances being made in controlled release fertiliser technology and the pressures of global food demand that drive their design. Written by Ian Campbell, Project Leader at Lucideon, the paper explores the different techniques used to control the release of nutrients in fertilisers and how new technologies are emerging to offer even more robust solutions.

With expertise in glass and ceramics, Lucideon’s experts have developed a novel inorganic controlled release technology (iCRT) for the controlled delivery of active products with a very high level of predictability. The particulate nature of the technology means there is no need for an external coating and the controlled release is not prevented if the carrier is broken, two big advantages over other controlled release fertilisers.

Ian Campbell said:

“Controlled release fertilisers offer significant advantages over conventional fertilisers in terms of nutrient delivery. They allow plants to take up more of the nutrients they contain, reduce run off to the surrounding environments, can maintain delivery for long periods and provide tailored compositions without environmental residues.

“With iCRT technology we see another step forward with controlled release fertilisers. The release mechanisms involved offer even greater predictability and control than other methods on the market”.

Lucideon’s iCRT technology can be loaded with various different actives for controlled release solutions. Lucideon is also working on projects for the controlled release of drugs with abuse-deterrent applications.

For more information on Lucideon’s iCRT technology, visit www.lucideon.com/controlled-release.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.